Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
Minhong Shen(Fudan University Shanghai Cancer Center), Yibin Kang(Rutgers, The State University of New Jersey), Joseph Bertino(Yale University), Michelle Rowicki(Princeton University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), John F. Jin, Lanjing Zhang(Rutgers, The State University of New Jersey), Yongna Xing(University of Wisconsin–Madison), Yong Wei(The Ohio State University), Min Yuan(Tongji University), Cheng-Guo Wu(Stanford University), Michael Raba, Zhi‐Ming Shao(Fudan University Shanghai Cancer Center), Aiping Zheng(Sichuan Agricultural University), Liling Wan(University of Pennsylvania), Heath A. Smith(AbbVie (United States)), Hahn Kim(Princeton University), Xiang Hang(Christian-Albrechts-Universität zu Kiel), Xin Lü(University of Notre Dame), Song‐Yang Wu(Shanghai Medical College of Fudan University), Stacy Remiszewski(ALS Biopharma (United States))
Cited by 83
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k